Evidence map›Paper›PMID 30086802›Full record

ArticleEpidemiology and infection2018

Sampling considerations for a potential Zika virus urosurvey in New York City.

C N Thompson, C T Lee, S Immerwahr, S Resnick, G Culp, S K Greene

Abstract read
In one paragraph

Article in Epidemiology and infection, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Rigorous surveillance is necessary for high confidence in end-of-outbreak declarations for Ebola and other infectious diseases.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

C N ThompsonBureau of Communicable Disease,New York City Department of Health and Mental Hygiene,Long Island City,New York,USA.ORCID 0000-0003-4490-6050
C T LeeBureau of Communicable Disease,New York City Department of Health and Mental Hygiene,Long Island City,New York,USA.
S ImmerwahrBureau of Epidemiology Services,New York City Department of Health and Mental Hygiene,Long Island City,New York,USA.
S ResnickBureau of IT Informatics,New York City Department of Health and Mental Hygiene,Long Island City,New York,USA.
G CulpBureau of Epidemiology Services,New York City Department of Health and Mental Hygiene,Long Island City,New York,USA.
S K GreeneBureau of Communicable Disease,New York City Department of Health and Mental Hygiene,Long Island City,New York,USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

In 2016, imported Zika virus (ZIKV) infections and the presence of a potentially competent mosquito vector (Aedes albopictus) implied that ZIKV transmission in New York City (NYC) was possible. The NYC Department of Health and Mental Hygiene developed contingency plans for a urosurvey to rule out ongoing local transmission as quickly as possible if a locally acquired case of confirmed ZIKV infection was suspected. We identified tools to (1) rapidly estimate the population living in any given 150-m radius (i.e. within the typical flight distance of an Aedes mosquito) and (2) calculate the sample size needed to test and rule out the further local transmission. As we expected near-zero ZIKV prevalence, methods relying on the normal approximation to the binomial distribution were inappropriate. Instead, we assumed a hypergeometric distribution, 10 missed cases at maximum, a urine assay sensitivity of 92.6% and 100% specificity. Three suspected example risk areas were evaluated with estimated population sizes of 479-4,453, corresponding to a minimum of 133-1244 urine samples. This planning exercise improved our capacity for ruling out local transmission of an emerging infection in a dense, urban environment where all residents in a suspected risk area cannot be feasibly sampled.

Indexed as

Diagnostic Tests, RoutineHumansNew York CityPopulation SurveillancePrevalenceSampling StudiesSensitivity and SpecificityUrineZika VirusZika Virus InfectionLocal transmissionsamplingurosurveyZika virus

Identifiers

PMID30086802
PMCPMC6948012

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.